We are live on
!
Find out more
InMed Pharmaceuticals
9 hedge funds and large institutions have $206K invested in InMed Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
29% more funds holding
Funds holding: 7 → 9 (+2)
2.84% more ownership
Funds ownership: 8.1% → 10.94% (+2.8%)
14% less capital invested
Capital invested by funds: $241K → $206K (-$34.6K)
Holders
9
Holders Change
+2
Holders Change %
+28.57%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
2
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$44.3K |
| 2 |
VF
Virtu Financial
New York
|
+$18.8K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$17.6K |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
+$17.6K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$7.25K |
Top Sellers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$13.5K |
| 2 |
Jane Street
New York
|
-$12.7K |